321 related articles for article (PubMed ID: 20033389)
1. [Scleroderma].
Distler O; Gay S
Internist (Berl); 2010 Jan; 51(1):30-8. PubMed ID: 20033389
[TBL] [Abstract][Full Text] [Related]
2. [Scleroderma in childhood and adolescence. New aspects on classification, etiology and therapy].
Girschick HJ
Z Rheumatol; 2008 Mar; 67(2):128-36. PubMed ID: 18299854
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis.
Denton CP; Khanna D
Lancet; 2017 Oct; 390(10103):1685-1699. PubMed ID: 28413064
[TBL] [Abstract][Full Text] [Related]
4. Clinical Treatment Options in Scleroderma: Recommendations and Comprehensive Review.
Zhao M; Wu J; Wu H; Sawalha AH; Lu Q
Clin Rev Allergy Immunol; 2022 Apr; 62(2):273-291. PubMed ID: 33449302
[TBL] [Abstract][Full Text] [Related]
5. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
6. [Systemic sclerosis in 2017].
Soukup T; Veleta T
Vnitr Lek; 2018; 64(2):146-154. PubMed ID: 29595279
[TBL] [Abstract][Full Text] [Related]
7. [Systemic sclerosis--clinical course and treatment possibilities].
Szymańska E; Maj M; Rudnicka L
Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
[TBL] [Abstract][Full Text] [Related]
8. [Systemic sclerosis-clinical picture, diagnosis, and treatment].
Becker MO; Distler O; Maurer B
Hautarzt; 2019 Sep; 70(9):723-741. PubMed ID: 31384958
[TBL] [Abstract][Full Text] [Related]
9. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy.
Strange G; Nash P
Int J Rheum Dis; 2009 Sep; 12(3):192-206. PubMed ID: 20374346
[TBL] [Abstract][Full Text] [Related]
10. Systemic and localized scleroderma.
Chung L; Lin J; Furst DE; Fiorentino D
Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
Li SC
Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
[TBL] [Abstract][Full Text] [Related]
12. [Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].
Mittag M; Haustein UF
Hautarzt; 1998 Jul; 49(7):545-51. PubMed ID: 9715381
[TBL] [Abstract][Full Text] [Related]
13. Systemic sclerosis/scleroderma: a treatable multisystem disease.
Hinchcliff M; Varga J
Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
[TBL] [Abstract][Full Text] [Related]
14. [Systemic sclerosis].
Legendre P; Mouthon L
Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
[TBL] [Abstract][Full Text] [Related]
15. [Juvenile scleroderma].
de Mâcedo PA; Shinjo SK; Goldenstein-Schainberg C
Acta Reumatol Port; 2008; 33(3):289-97. PubMed ID: 18846006
[TBL] [Abstract][Full Text] [Related]
16. [Lung impairment in systemic sclerosis].
Knoop H; Arinir U; Kreuter A; Walther JW; Schultze-Werninghaus G; Rohde G
Pneumologie; 2009 Sep; 63(9):497-507. PubMed ID: 19708006
[TBL] [Abstract][Full Text] [Related]
17. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
Reed J; Pope J
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
[TBL] [Abstract][Full Text] [Related]
18. Renal involvement in systemic sclerosis.
Scheen M; Dominati A; Olivier V; Nasr S; De Seigneux S; Mekinian A; Issa N; Haidar F
Autoimmun Rev; 2023 Jun; 22(6):103330. PubMed ID: 37031831
[TBL] [Abstract][Full Text] [Related]
19. [Systemic sclerosis. Objectives for the treatment].
Maurer B; Walder M; Gay RE; Gay S; Distler O
Z Rheumatol; 2009 Feb; 68(1):37-43. PubMed ID: 19145444
[TBL] [Abstract][Full Text] [Related]
20. Systemic Sclerosis and Pulmonary Disease.
Ngo K
Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
